Stephen B. Solomon

Active 2000–2025

124
Papers
20,949
Citations
73
h-index
118
i10-index

Citations

Citations per year for Stephen B. Solomon1993: 2 citations1996: 1 citations1999: 1 citations2001: 2 citations2002: 4 citations2003: 19 citations2004: 10 citations2005: 23 citations2006: 41 citations2007: 46 citations2008: 49 citations2009: 34 citations2010: 36 citations2011: 55 citations2012: 63 citations2013: 83 citations2014: 90 citations2015: 158 citations2016: 230 citations2017: 281 citations2018: 303 citations2019: 823 citations2020: 923 citations2021: 986 citations2022: 794 citations2023: 658 citations2024: 916 citations2025: 421 citations2026: 8 citations1994–1995: no citations, so these years are not shown1997–1998: no citations, so these years are not shown2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,743 citing papers, 28.4% of this breakdownChina: 1,156 citing papers, 12% of this breakdownUnited Kingdom: 539 citing papers, 5.6% of this breakdownItaly: 503 citing papers, 5.2% of this breakdownGermany: 438 citing papers, 4.5% of this breakdownCanada: 381 citing papers, 4% of this breakdownFrance: 381 citing papers, 3.9% of this breakdownNetherlands: 320 citing papers, 3.3% of this breakdownJapan: 303 citing papers, 3.1% of this breakdownSpain: 302 citing papers, 3.1% of this breakdownAustralia: 239 citing papers, 2.5% of this breakdownSwitzerland: 225 citing papers, 2.3% of this breakdown
0%28.4%Other 22.1%

Fields

  • Medicine71.4%
  • Biochemistry, Genetics and Molecular Biology17.4%
  • Engineering5.5%
  • Immunology and Microbiology2.2%
  • Health Professions1.1%
  • Computer Science0.8%
  • Other1.6%

Topics

  • Prostate Cancer Treatment and Research8.2%
  • Hepatocellular Carcinoma Treatment and Prognosis4.2%
  • Cancer Genomics and Diagnostics3.3%
  • Cancer Immunotherapy and Biomarkers3.3%
  • Cancer Cells and Metastasis3.2%
  • Prostate Cancer Diagnosis and Treatment3.1%
  • Other74.7%

Coauthors

All papers

Open in search
  1. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 3,701

  2. A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 cited by 560

  3. Organoid Cultures Derived from Patients with Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen B. Solomon, James A. Eastham, Ping Chi, Brett S. Carver, Mark A. Rubin, Howard I. Scher, Hans Clevers, Charles L. Sawyers, Yu Chen - Cell 2014 cited by 1,588

  4. Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barry S. Taylor, Marc Ladanyi, Diana Mandelker, Liying Zhang, Victor E. Reuter, Philip W. Kantoff, David B. Solit, Michael F. Berger, Charles L. Sawyers, Nikolaus Schultz, Howard I. Scher - JCO Precision Oncology 2017 cited by 531

  5. Intratumoral Injection of Clostridium novyi -NT Spores in Patients with Treatment-refractory Advanced Solid Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary Varterasian, Khashayarsha Khazaie, Mrinal M. Gounder - Clinical Cancer Research 2020 cited by 155

  6. Radiotheranostics: a roadmap for future development

    Authors: , , , , , , , , - The Lancet Oncology 2020 cited by 303

  7. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 591

  8. Image-Guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael C. Soulen, Masatoshi Tanaka, Thomas J. Vogl, Bradford J. Wood, S. Nahum Goldberg - Journal of Vascular and Interventional Radiology 2014 cited by 1,334

  9. A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2016 cited by 224

  10. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes—A 10-year Experience at a Single Center

    Authors: , , , , , , , , , , , , , , , - Radiology 2015 cited by 370

  11. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control

    Authors: , , , , , , , , , , - Journal of Vascular and Interventional Radiology 2017 cited by 276

  12. Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexis Kelekis, Hyun S. Kim, Thomas Kröncke, Sharon W. Kwan, Min Woo Lee, Fred T. Lee, Edward Lee, Ping Liang, Birgit I. Lissenberg‐Witte, David Lu, David C. Madoff, Giovanni Mauri, Maria Franca Meloni, Robert Morgan, G. Nadolski, Govindarajan Narayanan, Isabel G. Newton, Boris Nikolic, Franco Orsi, Philippe L. Pereira, Uei Pua, Hyunchul Rhim, Jens Ricke, William S. Rilling, Riad Salem, Hester J. Scheffer, Constantinos T. Sofocleous, Luigi Solbiati, Stephen B. Solomon, Michael C. Soulen, Daniel Y. Sze, Raman Uberoi, Thomas J. Vogl, David S. Wang, Bradford J. Wood, S. Nahum Goldberg, Martijn R. Meijerink - Radiology 2021 cited by 169

  13. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 cited by 377

  14. Macrophage-secreted TGF-β1 contributes to fibroblast activation and ureteral stricture after ablation injury

    Authors: , , , , , , , , - American Journal of Physiology-Renal Physiology 2019 cited by 128

  15. Margin Size is an Independent Predictor of Local Tumor Progression After Ablation of Colon Cancer Liver Metastases

    Authors: , , , , , , , , , , , , - CardioVascular and Interventional Radiology 2012 cited by 341

  16. Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joanne F. Chou, Marinela Capanu, Joseph P. Erinjeri, Stephen B. Solomon, Yoshiya Yamada, Nancy E. Kemeny, Christopher H. Crane, Leonard B. Saltz - Clinical Cancer Research 2021 cited by 86

  17. ICRP Publication 126: Radiological Protection against Radon Exposure

    Authors: , , , , , , , , , - Annals of the ICRP 2014 cited by 295

  18. Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT

    Authors: , , , , , , , , , , , , - Journal of Nuclear Medicine 2016 cited by 183

  19. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression

    Authors: , , , , , , , , , - European Radiology 2018 cited by 134

  20. Assessment of Advanced Diagnostic Bronchoscopy Outcomes for Peripheral Lung Lesions: A Delphi Consensus Definition of Diagnostic Yield and Recommendations for Patient-centered Study Designs. An Official American Thoracic Society/American College of Chest Physicians Research Statement

    Authors: , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2024 cited by 123

  21. 3D margin assessment predicts local tumor progression after ablation of colorectal cancer liver metastases

    Authors: , , , , , , , , , - International Journal of Hyperthermia 2022 cited by 66

  22. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2016 cited by 185

  23. Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation (SOLSTICE)

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2020 cited by 127

  24. Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy

    Authors: , , , , , , - Cancer Research 2011 cited by 278